You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure

https://doi.org/10.1136/ebm.7.3.81

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • Sources of funding: Bristol-Myers Squibb Institute for Medical Research and Sanofi-Synthelabo.

    • For correspondence: Dr E J Lewis, Rush–Presbyterian–St. Luke's Medical Center, Chicago, Illinois, USA.